E. Fleury
Papers
1
Total Citations
2
H-Index
1
About
Dr. E. Fleury is a leading researcher at the intersection of radiation oncology and artificial intelligence, with a primary focus on optimizing treatment for ocular malignancies, particularly uveal melanoma. Her most significant contribution is the development of an AI-based clinical decision-making tool that predicts dosimetric and clinical outcomes for patients with uveal melanoma, enabling rapid, personalized selection between stereotactic radiation therapy (SRT) and proton therapy without the need for lengthy, resource-intensive plan comparisons. This work, published in 2025, has already garnered 2 citations, reflecting its immediate relevance in a field where treatment precision is critical for vision preservation. Dr. Fleury’s research addresses a pressing clinical challenge: the time-consuming process of comparing multiple radiation modalities for each patient. By integrating machine learning with routine clinical parameters, her tool streamlines decision-making, potentially improving access to optimal therapy and reducing treatment delays. Her innovative approach positions her at the forefront of AI-driven personalized medicine in radiation oncology, with implications that extend beyond ocular tumors to broader applications in treatment planning and clinical workflow efficiency.
Research Focus
Key Achievements
Top Papers
- 1